CAQK Peptide: A Promising Breakthrough for Traumatic Brain Injury Treatment
Researchers have discovered that a four-amino acid peptide called CAQK can specifically target damaged brain tissue and reduce inflammation and cell death following traumatic brain injury—a condition with no currently approved drug treatments.